PLA2G7 Antibody, HRP conjugated
Product Specifications
CAS Number
9007-83-4
Gene Aliases
Platelet-activating factor acetylhydrolase precursor, 1 alkyl 2 acetylglycerophosphocholine esterase, 1-alkyl-2-acetylglycerophosphocholine esterase, 2 acetyl 1 alkylglycerophosphocholine esterase, 2-acetyl-1-alkylglycerophosphocholine esterase, EC 3.1.1.47 PAF acetylhydrolase PAF 2-acylhydrolase LDL associated phospholipase A2, Group VIIA phospholipase A2, Group-VIIA phospholipase A2, gVIIA PLA2, gVIIA-PLA2, LDL associated phospholipase A2, LDL PLA (2) , LDL PLA2, LDL-associated phospholipase A2, LDL-PLA (2) , Lipoprotein associated phospholipase A2, LP PLA2, PAF 2 acylhydrolase, PAF 2 acylhydrolase LDL associated phospholipase A2, PAF 2-acylhydrolase, PAF acetylhydrolase, PAFA_HUMAN, PAFAD, PAFAH, Phospholipase A2, group VII (platelet activating factor acetylhydrolase, plasma) , PLA2G7, Platelet activating factor acetylhydrolase 2, Platelet activating factor acetylhydrolase, Platelet-activating factor acetylhydrolase
UniProt
Q13093
Host
Rabbit
Antigen Species
Human
Reactivity
Human
Target Antigen
Recombinant Human Platelet-activating factor acetylhydrolase protein (49-441AA)
Target
PLA2G7
Clonality
Polyclonal
Conjugation
HRP
Applications
ELISA
Field of Research
Immunology
Purification Method
>95%, Protein G purified
Form
Liquid
Buffer
0.03% Proclin 300, 50% glycerol, 0.01M PBS, pH 7.4.
Storage Conditions
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Fragment
IgG
More Discoveries
Explore Other Products
Browse additional items from our catalog
RG-A262183-01 10 mg
α-Ethyltryptamine; Etryptamine; Ro 3-1932 (controlled substance)
Sign In for Pricing
View Details RG-A262183-02 25 mg
α-Ethyltryptamine; Etryptamine; Ro 3-1932 (controlled substance)
Sign In for Pricing
View Details 
RG-A262183-03 50 mg
α-Ethyltryptamine; Etryptamine; Ro 3-1932 (controlled substance)
Sign In for Pricing
View Details RG-A262183-04 100 mg
α-Ethyltryptamine; Etryptamine; Ro 3-1932 (controlled substance)
Sign In for Pricing
View Details 